Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SMRT Labs was a Canadian medical device and thermal screening company focused on commercializing ThermalPass, a walk-through, touchless temperature screening system designed for public-space screening during the COVID-19 era. The business appears to have been structured as a joint venture between Predictiv AI and Commersive Solutions to bring the ThermalPass offering to market. Available sources describe early sales traction, but the venture reportedly failed to meet targets as pandemic-driven market demand and regulations changed. Predictiv AI exited the joint venture in November 2021 by transferring its stake to Commersive Solutions, and SMRT Labs later entered bankruptcy proceedings in February 2023. Based on the available evidence, SMRT Labs was a healthcare-related device company, but not a biotech or therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SMRT Labs.